| Literature DB >> 28349121 |
Mude Shecho1, Naod Thomas1, Jelalu Kemal2, Yimer Muktar2.
Abstract
A cross-sectional study was carried out to determine antimicrobial drug resistance patterns of E. coli O157:H7 isolates and estimate the level of the pathogen. A total of 194 cloacae swab samples were collected randomly in two poultry farms. Standard cultural, biochemical, and serological (latex agglutination) methods were used to isolate E. coli O157:H7. The isolates were subjected to antimicrobial susceptibility testing using disc diffusion method. Out of 194 cloacae samples examined, 13.4% (n = 26) were found to be positive for E. coli O157:H7. The finding indicated differences in E. coli O157:H7 infection among the different risk factors. Chicken from Adele Poultry Farm showed higher E. coli O157:H7 infection (OR = 3.89) than Haramaya University poultry farm and young birds had more infection (OR = 4.62) than adult birds. Of the total 14 antimicrobials included in the panel of study, the susceptibility results were varied with 96.15% and 0% E. coli O157:H7 isolates expressing resistance to erythromycin, clindamycin, spectinomycin, and ciprofloxacin, respectively. Multidrug resistance to more than two antimicrobial agents was detected in 24 (92.30%) of the isolates. The study showed high presence of antimicrobial resistant isolates of E. coli O157:H7. Further study is required to better understand the ecology and evolution of bacterial resistance to antimicrobial agents.Entities:
Year: 2017 PMID: 28349121 PMCID: PMC5350295 DOI: 10.1155/2017/8264583
Source DB: PubMed Journal: J Vet Med ISSN: 2314-6966
Figure 1Map showing the study area.
Zone diameter interpretive standard chart for Enterobacteriaceae [11].
| Antimicrobial agents and symbols | Disc potency ( | Zone diameter, nearest whole mm | ||
|---|---|---|---|---|
| Resistance | Intermediate | Susceptible | ||
| Amoxicillin (AML) | 20 | ≤13 | 14–16 | ≥17 |
| Ampicillin (AMP) | 10 | ≤13 | 14–16 | ≥17 |
| Cefoxitin (FOX) | 30 | ≤14 | 15–17 | ≥18 |
| Chloramphenicol (C) | 30 | ≤12 | 13–17 | ≥18 |
| Ciprofloxacin (CIP) | 5 | ≤14 | 15–17 | ≥21 |
| Clindamycin (CLI) | 30 | ≤16 | — | ≥17 |
| Erythromycin (E) | 15 | ≤13 | 14–22 | ≥18 |
| Gentamycin (CN) | 10 | ≤12 | 13-14 | ≥15 |
| Kanamycin (K) | 30 | ≤13 | 14–17 | ≥18 |
| Nalidixic acid (NAL) | 30 | ≤17 | — | ≥18 |
| Spectinomycin (SPT) | 30 | ≤11 | 12–14 | ≥15 |
| Streptomycin (S) | 10 | ≤11 | 12–14 | ≥15 |
| Tetracycline (TE) | 30 | ≤11 | 12–14 | ≥15 |
| Trimethoprim (TRI) | 5 | ≤13 | 14–17 | ≥17 |
Level of E. coli O157:H7 isolates with different hypothesized risk factors from Haramaya University and Adele Poultry Farms.
| Risk factors | Risk categories | Number examined | Number positive | Proportion (%) | OR (95% CI) |
|
|---|---|---|---|---|---|---|
| Source | HUPFa | 106 | 7 | 6.6 | 1 | |
| APFb | 88 | 19 | 21.6 | 3.89 (1.5–11.5) | 0.002 | |
| Age | Adult | 93 | 5 | 7.5 | 1 | |
| Young | 101 | 21 | 18.8 | 4.62 (1.6–16.3) | 0.021 | |
| Breed | Feyumi | 85 | 7 | 10.6 | 1 | |
| White Leghorn | 109 | 19 | 15.6 | 2.35 (0.9–6.9) | 0.310 | |
|
| ||||||
|
|
|
|
| |||
aHaramaya University Poultry Farm.
bAdele Poultry Farm.
Antimicrobial resistance profiles of isolated E. coli O157:H7 from Haramaya University and Adele Poultry Farms.
| Antimicrobial agents | Disc potency ( | Number of isolates | Susceptible | Intermediate | Resistant |
|---|---|---|---|---|---|
| Amoxicillin | 20 | 26 | 7 (26.92) | 10 (38.46) | 9 (34.61) |
| Ampicillin | 10 | 26 | 0 (0.0) | 2 (7.69) | 24 (92.30) |
| Cefoxitin | 30 | 26 | 2 (7.69) | 2 (7.69) | 22 (84.61) |
| Chloramphenicol | 30 | 26 | 25 (96.15) | 0 (0.0) | 1 (3.84) |
| Ciprofloxacin | 5 | 26 | 27 (100) | 0 (0.0) | 0 (0.0) |
| Clindamycin | 30 | 26 | 0 (0.0) | 1 (3.84) | 25 (96.15) |
| Erythromycin | 15 | 26 | 1 (3.84) | 0 (0.0) | 25 (96.15) |
| Gentamycin | 10 | 26 | 23 (88.46) | 1 (3.84) | 2 (7.69) |
| Kanamycin | 30 | 26 | 10 (38.46) | 12 (46.15) | 4 (15.38) |
| Nalidixic acid | 30 | 26 | 16 (61.53) | 3 (11.53) | 6 (23.07) |
| Spectinomycin | 30 | 26 | 18 (69.23) | 8 (30.76) | 0 (0.0) |
| Streptomycin | 10 | 26 | 17 (65.38) | 0 (0.0) | 9 (34.61) |
| Tetracycline | 30 | 26 | 2 (7.69) | 4 (15.38) | 20 (76.92) |
| Trimethoprim | 5 | 26 | 24 (92.30) | 0 (0.0) | 2 (7.69) |
Resistance patterns of E. coli O157:H7 isolates form Haramaya University and Adele Poultry Farms against 14 antimicrobial agents.
| Antimicrobials |
| |
|---|---|---|
| Frequency | % | |
| E, K | 1 | 4.16 |
| E, TE | 2 | 8.33 |
| E, C | 1 | 4.16 |
| E, CLI | 1 | 4.16 |
| E, SPT | 1 | 4.16 |
| E, AMP | 2 | 8.33 |
| E, FOX | 1 | 4.16 |
| E, CLI, TE | 1 | 4.16 |
| E, K, TE | 1 | 4.16 |
| CN, E, TE | 1 | 4.16 |
| E, C, CLI, AMP | 3 | 12.5 |
| E, FOX, C, AML | 1 | 4.16 |
| E, CLI, C, AMP | 1 | 4.16 |
| E, S, C, AML | 1 | 4.16 |
| E, AMP, TE, AML | 1 | 4.16 |
| CN, E, S, AMP | 1 | 4.16 |
| E, CLI, K, AMP, FOX, C, TE, AML | 2 | 8.33 |
| E, CLI, K, AMP, C, TE, TRI, AML | 1 | 4.16 |
| E, S, K, NAL, CLI, C, TE, TRI, AML | 1 | 4.16 |
|
| ||
|
|
|
|
E: erythromycin, S: streptomycin, Nal = nalidixic acid, K: kanamycin, AMP: ampicillin, TE: tetracycline, RIT: trimethoprim, AML: amoxicillin, CIP: ciprofloxacin, CN: gentamycin, FOX: cefoxitin, C: chloramphenicol, and SPT: spectinomycin.
Figure 2Multidrug resistant profiles of E. coli O157:H7 isolates of the farms.